GoAI
Get started
PW Medtech Group Limited logo

PW Medtech Group Limited

1358.HK

HKSEHealthcareMedical - Instruments & Supplies

Open in GoAI

Latest quote

HK$0.90

−HK$0.01 · -1.10%

Aug 24, 3:52 PM HKT

1358.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Industry
Medical - Instruments & Supplies
Sector
Healthcare
Headquarters
CN

Market position

Day range

Current HK$0.90

52-week range

Current HK$0.90

Open
HK$0.91
Previous close
HK$0.91
Volume
233K
Market cap
1.28B HKD
50-day average
HK$1.0482
-14.14% below average
200-day average
HK$1.1899
-24.36% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
-30.95M CNY
P/E (TTM)
12.27×
P/B (TTM)
0.3×
P/S (TTM)
1.33×
EV / EBITDA
-0.12×
Earnings yield
5.39%
Free cash flow yield
7.75%
Dividend yield
7.11%

Profitability & efficiency

Gross margin
49.48%
Operating margin
14.85%
Net margin
11.46%
Return on equity
2.39%
Return on assets
1.80%
Return on invested capital
1.99%

Financial health

Debt / equity
0.01×
Current ratio
10.89×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends298%194%90%-15%Gross margin, FY2021: 61.19%Gross margin, FY2022: 55.67%Gross margin, FY2023: 56.42%Gross margin, FY2024: 54.55%Gross margin, FY2025: 49.48%Operating margin, FY2021: 250.82%Operating margin, FY2022: 22.88%Operating margin, FY2023: 27.76%Operating margin, FY2024: 23.34%Operating margin, FY2025: 14.85%Net margin, FY2021: 272.34%Net margin, FY2022: 19.75%Net margin, FY2023: 22.69%Net margin, FY2024: 19.61%Net margin, FY2025: 11.46%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 61.19%. Gross margin FY2022 55.67%. Gross margin FY2023 56.42%. Gross margin FY2024 54.55%. Gross margin FY2025 49.48%. Operating margin FY2021 250.82%. Operating margin FY2022 22.88%. Operating margin FY2023 27.76%. Operating margin FY2024 23.34%. Operating margin FY2025 14.85%. Net margin FY2021 272.34%. Net margin FY2022 19.75%. Net margin FY2023 22.69%. Net margin FY2024 19.61%. Net margin FY2025 11.46%.

Income trends

Revenue

823.51M CNY+7.10%

Operating income

122.3M CNY-31.86%

Net income

94.37M CNY-37.41%
Income trends across reported periods896.42M CNY604.77M CNY313.11M CNY21.46M CNYRevenue, FY2021: 271.4M CNYRevenue, FY2022: 536.83M CNYRevenue, FY2023: 675.08M CNYRevenue, FY2024: 768.9M CNYRevenue, FY2025: 823.51M CNYOperating income, FY2021: 680.73M CNYOperating income, FY2022: 122.84M CNYOperating income, FY2023: 187.4M CNYOperating income, FY2024: 179.48M CNYOperating income, FY2025: 122.3M CNYNet income, FY2021: 739.12M CNYNet income, FY2022: 106.04M CNYNet income, FY2023: 153.18M CNYNet income, FY2024: 150.78M CNYNet income, FY2025: 94.37M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 271.4M CNY. Revenue FY2022 536.83M CNY. Revenue FY2023 675.08M CNY. Revenue FY2024 768.9M CNY. Revenue FY2025 823.51M CNY. Operating income FY2021 680.73M CNY. Operating income FY2022 122.84M CNY. Operating income FY2023 187.4M CNY. Operating income FY2024 179.48M CNY. Operating income FY2025 122.3M CNY. Net income FY2021 739.12M CNY. Net income FY2022 106.04M CNY. Net income FY2023 153.18M CNY. Net income FY2024 150.78M CNY. Net income FY2025 94.37M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue823.51M CNY768.9M CNY675.08M CNY536.83M CNY271.4M CNY
Cost of goods sold416.05M CNY349.46M CNY294.19M CNY238M CNY105.34M CNY
Gross profit407.46M CNY419.45M CNY380.9M CNY298.83M CNY166.06M CNY
Research and development48.41M CNY44.12M CNY41.13M CNY40.98M CNY20.25M CNY
Selling, general, and administrative268.86M CNY240.88M CNY195.11M CNY189.57M CNY123.09M CNY
Operating expenses285.16M CNY239.97M CNY193.5M CNY175.98M CNY514.68M CNY
Interest income43.41M CNY50.65M CNY43.83M CNY35.37M CNY57.34M CNY
Interest expense720K CNY374K CNY154K CNY464K CNY605K CNY
Depreciation and amortization137.15M CNY96.97M CNY98.26M CNY77.32M CNY30.91M CNY
Operating income122.3M CNY179.48M CNY187.4M CNY122.84M CNY680.73M CNY
Net income94.37M CNY150.78M CNY153.18M CNY106.04M CNY739.12M CNY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
0.06

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates0.630.40.17-0.07Q2 '21Q4 '21Q3 '22Q1 '23Q3 '23Q1 '24Q3 '24Q1 '25
Q2 2021, reported Jun 30, 2021: actual 0.582, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual -0.017, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Aug 31, 2022: actual 0.045, estimate —, surprise —, Comparison unavailable. Q1 2023, reported Mar 30, 2023: actual 0.033, estimate —, surprise —, Comparison unavailable. Q3 2023, reported Sep 1, 2023: actual 0.049, estimate —, surprise —, Comparison unavailable. Q1 2024, reported Mar 28, 2024: actual 0.058, estimate —, surprise —, Comparison unavailable. Q3 2024, reported Aug 31, 2024: actual 0.048, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual 0.056, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates718.85M524.64M330.44M136.23MQ2 '21No estimateQ4 '21No estimateQ3 '22MissQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24No estimateQ1 '25No estimate
Q2 2021, reported Jun 30, 2021: actual 160.28M HKD, estimate —, surprise —, Comparison unavailable. Q4 2021, reported Dec 31, 2021: actual 168.85M HKD, estimate —, surprise —, Comparison unavailable. Q3 2022, reported Aug 31, 2022: actual 250.81M HKD, estimate 677.47M HKD, surprise -62.98%, Miss. Q1 2023, reported Mar 30, 2023: actual 367.39M HKD, estimate 677.47M HKD, surprise -45.77%, Miss. Q3 2023, reported Sep 1, 2023: actual 344.99M HKD, estimate 677.47M HKD, surprise -49.08%, Miss. Q1 2024, reported Mar 28, 2024: actual 394.1M HKD, estimate 677.47M HKD, surprise -41.83%, Miss. Q3 2024, reported Aug 31, 2024: actual 363.43M HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 28, 2025: actual 457.95M HKD, estimate —, surprise —, Comparison unavailable.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.097

2025 complete year+2.6% since 2024

2026 partial: HK$0.02

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Jul 2, 2026

HK$0.02

Semi-Annual

Record Jul 6, 2026 · Payment Jul 31, 2026

Dividend

Ex-dividend Nov 3, 2025

HK$0.044

Semi-Annual

Record Nov 5, 2025 · Payment Dec 3, 2025

Dividend

Ex-dividend Jul 3, 2025

HK$0.053

Semi-Annual

Record Jul 7, 2025 · Payment Jul 25, 2025

Dividend

Ex-dividend Nov 4, 2024

HK$0.045

Semi-Annual

Record Nov 5, 2024 · Payment Dec 2, 2024

Dividend

Ex-dividend Jul 4, 2024

HK$0.0495

Semi-Annual

Record Jul 5, 2024 · Payment Jul 26, 2024

Dividend

Ex-dividend Sep 29, 2023

HK$0.049

Semi-Annual

Record Oct 3, 2023 · Payment Oct 24, 2023

1358.HK peers

WuXi AppTec Co., Ltd. logo

2359.HK

WuXi AppTec Co., Ltd.

HK$197.7

-3.94%

Jiangsu Hengrui Pharmaceuticals Co.,Ltd logo

1276.HK

Jiangsu Hengrui Pharmaceuticals Co.,Ltd

HK$46.46

-3.61%

BeOne Medicines AG logo

6160.HK

BeOne Medicines AG

HK$221.4

-2.89%

WuXi Biologics (Cayman) Inc. logo

2269.HK

WuXi Biologics (Cayman) Inc.

HK$48.60

-4.71%

Hansoh Pharmaceutical Group Company Limited logo

3692.HK

Hansoh Pharmaceutical Group Company Limited

HK$31.06

-6.11%

Innovent Biologics, Inc. logo

1801.HK

Innovent Biologics, Inc.

HK$99.50

-2.83%

Continue in GoAI

Research 1358.HK

research.disclaimer